302 related articles for article (PubMed ID: 21403444)
1. [Direct low-dose fentanyl patch (2.1mg) introduction for opioid naïve outpatients with cancer pain].
Hata A; Katakami N; Masuda Y; Nanjo S; Otsuka K; Kaji R; Fujita S; Iwamori S; Mifune Y; Orita H; Fukae M; Yamatani T
Gan To Kagaku Ryoho; 2011 Mar; 38(3):415-8. PubMed ID: 21403444
[TBL] [Abstract][Full Text] [Related]
2. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
5. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
8. Utilisation of transdermal fentanyl in Germany from 2004 to 2006.
Garbe E; Jobski K; Schmid U
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):191-8. PubMed ID: 21681850
[TBL] [Abstract][Full Text] [Related]
9. The use of transdermal fentanyl in cancer pain--a compliance study of outpatients in Taiwan.
Chiou TJ; Liu CY; Tzeng WF; Su YC; Weng YC; Hung CJ; Tang Y; Chen YJ;
Am J Hosp Palliat Care; 2010 Feb; 27(1):31-7. PubMed ID: 19801533
[TBL] [Abstract][Full Text] [Related]
10. Low doses of transdermal fentanyl in opioid-naive patients with cancer pain.
Mercadante S; Porzio G; Ferrera P; Aielli F; Adile C; Ficorella C
Curr Med Res Opin; 2010 Dec; 26(12):2765-8. PubMed ID: 21034376
[TBL] [Abstract][Full Text] [Related]
11. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
12. [Research from the Palliative Care Department in Poznań on treatment of neoplasm pain with Durogesic (transdermal fentanyl)].
Leppert W; Luczak J; Gorzelińska L; Kozikowska J
Przegl Lek; 2000; 57(1):59-64. PubMed ID: 10907375
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
Payne R
Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
[TBL] [Abstract][Full Text] [Related]
14. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
15. [Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain].
Yamazaki K; Fujio N; Ishikawa N; Watanabe H; Kameyama M
Gan To Kagaku Ryoho; 2012 Mar; 39(3):405-8. PubMed ID: 22421768
[TBL] [Abstract][Full Text] [Related]
16. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
[TBL] [Abstract][Full Text] [Related]
17. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
Berliner MN; Giesecke T; Bornhövd KD
Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
19. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of low-dose matrix-type transdermal fentanyl applied for opioid initiation].
Yamaguchi Y; Kagawa Y; Yoneta E; Kunimori K
Gan To Kagaku Ryoho; 2012 May; 39(5):765-8. PubMed ID: 22584328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
